Design

We conducted a pragmatic, multisite, randomised controlled trial of the ‘Don't Panic’ course v. a waiting-list control group. Measurements were taken at baseline (T ₀), and at post-test after 3 months (T ₁). To monitor effect maintenance over time the early intervention group received an extended follow-up at 9 months after baseline, i.e. 6 months after the end of the course (T ₂). The randomisation took place after administration of the Mini International Neuropsychiatric Interview–Plus (MINI–Plus) ^{Reference Sheehan, Lecrubier, Sheehan, Amorim, Janavs and Weiller8} and was carried out centrally by an independent third party. A blocked randomisation scheme was used, stratified by mental health centre, subthreshold panic disorder v. mild panic disorder, and by presence v. absence of co-occurring agoraphobia. The latter was included because it was assumed that agoraphobia is a prognostically relevant factor for treatment response in panic disorder. This procedure ensured that participants with and without panic disorder or agoraphobia were equally distributed across both trial arms. Power calculations indicated that 129 participants per group were required in order to detect a difference in symptom reduction, equivalent to a standardised effect size of at least 0.35 in a two-sided test at alpha = 0.05 and a power of (1-beta) = 0.80. The trial protocol was approved by an independent medical ethics committee (METIGG) and was conducted between September 2005 and July 2007.

Participants

Participants were recruited from the general adult population in The Netherlands. They were eligible if over 18 years of age and presenting with subthreshold or mild panic disorder, defined as having symptoms of panic disorder falling below the cut-off of 13 on the Panic Disorder Severity Scale–Self Report (PDSS–SR). ^{Reference Michelson, Allgulander, Dantendorfer, Knezevic, Maierhofer and Micev9} Exclusion criteria were: severe panic disorder (PDSS–SR >12), current psychological treatment for panic disorder-related complaints, presence of other severe mental or social problems, suicidal intention warranting treatment or likely to interfere with participation in the group course as assessed by an experienced psychologist during intake. People meeting one of the exclusion criteria were advised to seek regular treatment. If a participant used medication for anxiety or depression (e.g. benzodiazepines or antidepressants) it was agreed to keep medication use stable during the study period. Eligible participants received a complete description of the study and only entered the trial once informed consent was obtained.

Participants were recruited according to the standard procedure for recruiting participants for preventive services in The Netherlands. All community mental health centres in The Netherlands have a prevention department, offering preventive and early interventions to the general population in their region. Many of these interventions are aimed at people with subthreshold disorders, and participants are recruited through media announcements, flyers in libraries and healthcare buildings, and via banners placed on the internet. In the current study, this was precisely the recruitment strategy used to recruit participants. There were 17 participating community mental health centres. For screening, the standard procedures employed by the community mental health centres were used. First, people who showed interest received more information about the course and the study. They also had an initial screening interview by telephone to ascertain the presence of panic symptoms. Second, potential participants had an interview with an experienced psychologist from a community mental health centre. In this interview, the inclusion and exclusion criteria as described earlier were checked. In addition, potential participants were interviewed by trained interviewers from the Trimbos Institute (Netherlands Institute of Mental Health and Addiction) using the MINI–Plus ^{Reference Sheehan, Lecrubier, Sheehan, Amorim, Janavs and Weiller8,Reference Van Vliet, Leroy and Van Megen10} for research purposes. This was done to assess the DSM–IV ¹¹ panic disorder status as well as the possible presence of concurrent agoraphobia, and to exclude people presenting with severe depressive disorder.

Interventions

We developed an early intervention for panic symptoms, called the ‘Don't Panic’ course. The course was based on cognitive–behavioural principles that have been shown to be effective in the treatment of the full-blown disorder. ^{Reference Bakker12–Reference Van Balkom, Bakker, Spinhoven, Blaauw, Smeenk and Ruesink14} This course was developed specifically for adults. It consisted of 8 weekly sessions of 2 h each in groups of 6–12 participants. The ‘Don't Panic’ course manual was used by the psychologist and prevention worker offering the intervention and there was an accompanying workbook for the participants. ^{Reference Meulenbeek, Herzmanatus, Smit, Willemse and Van der Zanden15} To ensure the integrity of intervention delivery, the course instructors were trained in offering the course and working with the course manual by the Trimbos Institute (i.e. a 1-day training programme by P.M.). In addition, they had access to a help desk when questions arose while offering the intervention. Participants were taught to examine their panic attacks and the possible causes, to use techniques to control anxiety levels and to develop coping skills. The course included:

1. (a) psychoeducation on the psychological and physiological nature of anxiety and panic attacks;

2. (b) lifestyle changes to improve their physical condition;

3. (c) stress management to prevent constant tension by learning effective ways to cope with stress;

4. (d) relaxation training to reduce physiological arousal;

5. (e) cognitive restructuring to challenge and correct dysfunctional cognitions about panic and anxiety;

6. (f) interoceptive exposure to reduce the fear of somatic sensations;

7. (g) ‘in vivo’ exposure to reduce agoraphobic avoidance and safety behaviours; and

8. (h) techniques aimed at relapse prevention.

Participants evaluated their progress during the course. Three months after completion of the course a booster session was offered to the participants. Each session was structured and encompasses a review of homework assignments, feedback, rehearsals, information about the upcoming topics and practical skills training. The course was extensively pilot tested before entering the clinical trial stage. ^{Reference Meulenbeek, Willemse, Smit, Smits, Van Balkom and Spinhoven16}

The control group were put on a waiting list. These individuals were free to make use of other interventions for panic disorder. Therefore the control group could also be described as a care as usual group – with one difference: individuals in the waiting list group knew that they could start the course 1 month after the intervention group had completed the intervention.

Measures

We used the PDSS–SR and the MINI–Plus as the primary outcome measures. Severity of panic symptoms was measured with the PDSS–SR. ^{Reference Shear, Rucci, Williams, Frank, Grochocinski and Vander Bilt17,Reference Van der Meer and Burgerhout18} The PDSS–SR generates a total score ranging from 0 to 28, with a higher score indicating more severe panic symptoms. A cut-off score of 13 discriminates between mild and severe panic disorder. ^{Reference Michelson, Allgulander, Dantendorfer, Knezevic, Maierhofer and Micev9} To assess the DSM–IV panic disorder and agoraphobia status the MINI–Plus ^{Reference Sheehan, Lecrubier, Sheehan, Amorim, Janavs and Weiller8,Reference Van Vliet, Leroy and Van Megen10} was used. To exclude severe major depressive disorder the depression section of the MINI–Plus was supplemented with the Sheehan Disability Scale. ^{Reference Leon, Olfson, Portera, Farber and Sheehan19} Individuals presenting with severe impairments in at least two areas of role functioning because of a depressive disorder were excluded from the study. The interviews were conducted by trained interviewers who received 1 day's training from the Trimbos Institute (P.M. and G.W.). For efficiency, the interviews were conducted by telephone; an approach that can be justified from a psychometric point of view. ^{Reference Rohde, Lewinsohn and Seeley20,Reference Evans, Kessler, Lewis, Peters and Sharp21} The interviewers were masked to the randomisation status of the participants. The following self-rated questionnaires were used as secondary outcome measures. For agoraphobic avoidance the Mobility Inventory ^{Reference Chambless, Caputo, Jasin, Gracely and Williams22,Reference De Beurs23} was employed. The subscale for anxiety of the Hospital Anxiety and Depression Scale (HADS–Anxiety) ^{Reference Zigmond and Sniath24,Reference Spinhoven, Ormel, Sloekers, Kempen, Speckens and Van Hemert25} was used to indicate anxiety levels. The Beck Depression Inventory (BDI–II) ^{Reference Beck, Steer and Brown26,Reference Van der Does27} was used to assess depressive symptoms. All outcome measures have good psychometric properties. The self-report questionnaires were utilised for all three measurements and completed at home. The MINI–Plus was conducted by telephone at T ₀ and T ₁.

Analyses

As the primary outcome we compared the proportion of participants manifesting with a clinically significant change on the PDSS–SR across both groups. A clinically significant change was defined according to the criteria proposed by Jacobson & Truax: ^{Reference Jacobson and Truax28} a change should move from a dysfunctional distribution to a functional one, and the change should be statistically reliable in the sense that the observed change cannot be attributed to measurement error. As we studied a population with subthreshold and mild panic disorder, we considered scores below one standard deviation of the mean pre-test score on the PDSS–SR as falling within the functional range. ^{Reference Greeven, Van Balkom, Visser, Merkelbach, Van Rood and Van Dyck29} Participants meeting the Jacobson & Truax criterion were coded 1 (implying favourable treatment response, ‘success’) or else 0 (‘failure’). This binary outcome was used to obtain the odds ratio (OR) using the logistic regression model and the number needed to treat (NNT) using a linear probability model for a binomial outcome (i.e. a generalised linear model for a binomial distributed error-term and using identity as the link function).

We tried to obtain converging evidence for the central clinical outcome by also evaluating the effect on panic disorder status using the MINI/DSM–IV criteria. As indicated, the sample can be divided into two groups: people with relatively mild manifestations of MINI/DSM–IV panic disorder (n = 100) and those with subthreshold manifestations not meeting the diagnostic criteria (n = 117). The latter group is said to be ‘at risk’ of developing panic disorder. In this group we observed how many remained panic disorder-free at T ₁ (a favourable preventative outcome, ‘success’). However, when attention is paid to the former group presenting with mild panic disorder a favourable treatment response occurs when a participant is panic disorder free at T ₁ (‘success’). This allows a comparison of the proportion of successes across both trial groups. Again, this yields a binomial outcome with failure coded as 0, and success as 1. In a next step, this binary outcome was used to obtain the OR and NNT as before.

For outcomes on continuous measurement scales, such as the PDSS and the HADS, a Gaussian regression model was used to test the hypothesis of superior effects in the early intervention arm as compared with the waiting-list control group. We also calculated standardised between-group mean differences (Cohen's d effect size).

To test effect maintenance up to the extended follow-up at 9 months after baseline in the early intervention group, we used a paired-sample t-test to analyse the difference in mean score of the self-report measures in the early intervention group from T ₀ to T ₁, T ₀ to T ₂ and T ₁ to T ₂.

All analyses were conducted in agreement with the intention-to-treat principle, ^{Reference Everitt30} hence all participants were analysed in the group to which they were randomised, and missing end-points at follow-up were imputed using a regression model with the best available predictors of outcome and the best predictors for drop out. The first set of predictors is required to obtain the most precise estimates for the missing values; the latter set of predictors is used to correct for bias that may stem from differential loss to follow-up associated with T ₀ variables. ^{Reference Demirtas31}

In all analyses we accounted for the clustering of data induced by the multisite character of the study. Clustering violates the assumption of independence of observations, and may thus affect standard errors and P-values. So-called ‘robust standard errors’ and correct P-values were obtained using the first-order Taylor-series linearisation method. All analyses were conducted with Stata 9.2 for Windows. All tests were conducted using a two-sided significance level of P = 0.05.

Characteristics of the participants

A total of 586 people expressed an interest in the course. During a first screening by telephone it transpired that 210 of them had psychiatric symptoms other than panic related ones (e.g. related to social phobia or generalised anxiety) or there were practical obstacles (work, travel distance) that precluded their participation in the trial. The remaining 376 participants were interviewed by an experienced psychologist. A total of 217 participants entered the study and were randomised to the early intervention group (n = 109) or the control group (n = 108) (Fig. 1). The baseline characteristics of the study participants are presented in Table 1.

Fig. 1

Participants' flow through the study.

PDSS–SR, Panic Disorder Severity Scale–Self Report; MINI–Plus, Mini-International Neuropsychiatric Interview–Plus.

a. Participants can have more than one contraindication.

b. Including somatic problems (n = 11).

c. Including practical restraints.

Table 1

Baseline characteristics of the participants for total group, early intervention group and control group

	Total group (n = 217)	Early intervention group (n = 109)	Control group (n = 108)
Female, n (%)	154 (71)	77 (71)	77 (71)
Age, years: mean (s.d.) range	42 (12.4) 20-75	42 (12.9) 20-75	42 (11.8) 20-74
Married/living with partner, n (%)	169 (78)	83 (76)	86 (80)
Employed (paid), n (%)	151 (70)	75 (69)	76 (70)
Years of education, mean (s.d.)	14.04 (3.26)	14.07 (3.29)	14.01 (3.25)
MINI—Plus—Panic disorder: current, n (%)	100 (46)	50 (46)	50 (46)
MINI—Plus—Agoraphibia: current, n (%)	135 (62)	68 (62)	67 (62)
PDSS—SR, mean (s.d.) range	7.18 (3.23) 0-28	7.02 (3.24) 0-28	7.35 (3.24) 0-28
HADS—Anxiety, mean (s.d.) range	9.54 (3.83) 0-21	9.48 (3.94) 0-21	9.60 (3.74) 0-21
Mobility Inventory, mean (s.d.) range	1.96 (0.66) 1-5	1.89 (0.62) 1-5	2.02 (0.69) 1-5
BDI—II, mean (s.d.) range	12.46 (7.64) 0-63	11.96 (8.01) 0-63	12.97 (7.26) 0-63

In the sample, 71% were female. The mean age was 42 years, ranging from 20 to 75 years. Most participants were employed and were living with a partner (Table 1). The early intervention and the control group did not differ significantly with regard to sociodemographic and clinical characteristics. Almost 50% met the DSM–IV criteria of (mild) panic disorder at entry to the study, whereas 62% were diagnosed with agoraphobia. Overall, 194 (89%) participants completed the T ₁ self-report questionnaire, with no significant difference in response rate between both groups. Completers did not differ significantly from non-completers on any of the baseline variables. Follow-up data for 99 participants (91% of the early intervention group) were available at 6 months after completion of the course.

Clinically significant change

The functional range turned out to be a score below 3.95 on the PDSS–SR; this is 4-scale points below the cut-off score of 8 that may discriminate between the presence or absence of current DSM–IV panic disorder. ^{Reference Shear, Rucci, Williams, Frank, Grochocinski and Vander Bilt17,Reference Van der Meer and Burgerhout18} The reliable change on the PDSS–SR appeared to be a pre–post difference of at least 3.85 scale points. We coded for ‘success’ when a reliable pre–post change of 3.85 scale points had occurred and when, in addition, the cut-off value of 4 on the PDSS–SR was crossed. In the early intervention group, 43/109 (39%) participants v. 17/108 (16%) participants in the control group presented with a successful outcome: OR = 3.49, 95% CI 1.77–6.88, P = 0.001, NNT = 4.2 under an intention-to-treat analysis.

It was further tested whether there was any difference in the primary outcome between people with subthreshold panic disorder and those with mild panic disorder. A logistic regression analysis revealed no significant difference (OR = 0.88; robust s.e. = 0.6755; t = –0.16, P = 0.878).

Effect on MINI/DSM–IV diagnostic status

In the early intervention group, 89/109 (82%) participants presented with a favourable treatment response on the MINI–Plus compared with 75/108 (69%) participants in the control group (Table 2; OR = 1.96, 95% CI 1.05–3.66, P = 0.037, NNT = 8.2).

Table 2

Success on the Mini International Neuropsychiatric Interview–Plus (MINI-Plus) (n = 217)

	Early Intervention group (n = 109)		Control group (n = 108)
Panic disorder-status	n	%	n	%
Subthreshold panic disorder at T 0	59		58
Success (stayed panic disorder-free at T 1)	51	86	43	74
Mild panic disorder at T 0	50		50
Success (became panic disorder-free at T 1)	38	76	32	64
Total success on the MINI-Plus	89	82	75	69

Effect on panic severity

The course was found to have a beneficial effect on reducing panic severity levels compared with the waiting-list control group (PDSS–SR, P = 0.004). The mean score on the PDSS–SR at T ₁ for the early intervention group was 3.48 v. 5.77 for the control group. The standardised effect size on the PDSS–SR at T ₁ was 0.68; from a clinical perspective this can be interpreted as a large effect. ^{Reference Lipsey and Wilson32}

Other outcomes

The scores for the other outcomes are presented in Table 3. Undertaking the course was superior to being in the waiting-list control group on all outcomes. The between-group effect sizes for these secondary outcomes ranged from 0.31 to 0.59.

Table 3

Means and standard deviations for the early intervention and control group at baseline (T ₀) and post-test (T ₁) and effect sizes at post-test (T ₁)

	Early intervention (n = 109)	Control (n = 108)	Effect sizea	P b
Panic Disorder Severity Scale—Self Report (range 0-28)
T 0, mean (s.d.)	7.02 (3.24)	7.35 (3.24)
T 1, mean (s.d.)	3.48 (3.22)	5.77 (3.54)	0.68	0.004
Hospital Anxiety and Depression Scale, subscale Anxiety (range 0-21)
T 0, mean (s.d.)	9.48 (3.94)	9.60 (3.74)
T 1, mean (s.d.)	6.26 (3.93)	8.61 (4.00)	0.59	0.001
Mobility Inventory (range 1-5)
T 0, mean (s.d.)	1.89 (0.62)	2.02 (0.69)
T 1, mean (s.d.)	1.67 (0.57)	1.95 (0.70)	0.44	0.004
Beck Depression Inventory—Second edition (range 0-63)
T 0, mean (s.d.)	11.96 (8.01)	12.97 (7.26)
T 1, mean (s.d.)	9.20 (7.89)	11.58 (7.69)	0.31	0.036

There was no significant difference in the use of medication between the groups at baseline. In the early intervention group, 36 (33%) participants used medication at baseline, 3 (3%) started medication during the course and 9 (8%) stopped using medication. In the control group, 48 (44%) participants used medication at baseline, 7 (6%) started and 8 (7%) stopped medication in the period between baseline and T ₁. Therefore, it is unlikely that the present findings can be explained by changes in medication use.

Six-month follow-up

The difference in mean scores on the self-report measures of the early intervention group from T ₀ to T ₁ and T ₀ to T ₂ were all significant at P<0.001. The mean score at T ₂ on the PDSS–SR (mean = 3.48, s.d. = 3.42) and the HADS–Anxiety (mean 6.13, s.d. = 3.81) of the early intervention group did not differ significantly from T ₁ (PDSS–SR: P = 0.995; HADS–Anxiety: P = 0.627). The mean score at T ₂ on the Mobility Inventory (mean = 1.61, s.d. = 0.60) and the BDI–II (mean 7.83, s.d. = 7.53) were significantly lower than at T ₁ (Mobility Inventory: P = 0.037; BDI–II: P = 0.007). The results suggest that the improvement after the course was maintained at 6-month follow-up.

Acceptability

After each session the attendance of the participants was registered and it was ascertained whether they had carried out their homework assignments. On the basis of this information it can be concluded that four participants in the early intervention group (4%) did not start the course. Reasons for not starting were beginning another course and lack of time because of work. Eighty-two (75%) participants in the early intervention group completed the course (completing the course is defined as attending at least six sessions). The main reasons for not completing the course were practical obstacles (work, illness). The mean number of attended sessions was 6.3 sessions. Of the attending participants, 83% had completed their homework for each session, 15% did not complete their homework for one session, 1.4% for two sessions, 0.5% for three sessions and 0.5% for four sessions. Therefore, compliance with the course was satisfactory.

The post-test self-report questionnaire of the early intervention group provided information about satisfaction with the course (response rate 83%, n = 91). The participants evaluated the course positively (organisational aspects, coaching, content, group sessions and workbook). Asked whether the course had contributed to being better able to manage panic complaints, 88% answered in the affirmative. The participants rated psychoeducation about anxiety and panic attacks, changing lifestyle, relaxation training and cognitive restructuring as most helpful. On a scale ranging from 1 ‘very bad’ to 10 ‘excellent’, the mean rating for the course was 7.8 (range: 5–9, s.d. = 0.945). These findings add to the impression that the course is acceptable.

Main findings

We hypothesised that the ‘Don't Panic’ course would be superior in reducing panic disorder symptomatology. The results show that the participants in the early intervention group made significantly more improvement on panic symptoms compared with the waiting-list control group on all outcomes. Furthermore, symptoms of depression declined, as measured by the BDI–II. This finding is important because people with panic symptoms may also have higher rates of depressive symptoms. ^{Reference Birchall, Brandon and Taub33} To our knowledge this is the first study that shows the effectiveness of an early group intervention for self-referred adults with sub-threshold or mild panic disorder. The improvements were maintained over 6 months after the course. These findings are in agreement with previous findings on prevention and early intervention in panic disorder. ^{Reference Gardenswartz and Craske6,Reference Swinson, Soulios, Cox and Kuch7} The difference between the present sample and clinical samples ^{Reference Shear, Rucci, Williams, Frank, Grochocinski and Vander Bilt17,Reference Van der Meer and Burgerhout18} is emphasised by the substantially lower mean degree of severity of panic symptoms as measured with the PDSS–SR at baseline. To explore the effectiveness of the intervention in other samples, future research might also use clinical samples, particularly in primary care settings. The finding that there was no difference in the primary outcome between people with subthreshold panic disorder and those with mild panic disorder could have implications for general clinical practice because it seems to indicate that an early intervention in less severe panic could perhaps best be implemented broadly as a first step in a stepped care mental health approach. People with panic symptoms will vary in the type and intensity of interventions they prefer. To increase the coverage of the target population, exploring alternative ways of intervening such as collaborative care and guided self-help may address that need.

Acceptability of the course

The participants who evaluated the course assessed it as positive and helpful. Compliance with the course was satisfactory. These findings suggest the course is suitable and acceptable. This is furthermore supported by the fact that many (about 40%) community mental health centres in The Netherlands now offer the course on a regular basis. In addition, a group intervention may be more cost-effective than an individual intervention. An economic evaluation of the intervention for a subgroup of the sample (i.e. people with subthreshold panic disorder) showed that it may be acceptable from a cost-effectiveness point of view. ^{Reference Smit, Willemse, Meulenbeek, Koopmanschap, Van Balkom and Spinhoven34} The results may be highly generalisable, as the course was examined in its natural setting and the recruitment strategy of the study and the community mental health centres that offer the course are comparable. Another strength of this study was the high response rate.

Limitations

We recognise a number of limitations in this study. First, because of the absence of a placebo control it is not clear whether non-specific components of the course such as social interaction and expectation of gain contribute to the early intervention effect. Future research should use placebo-controlled designs to overcome this limitation. Second, the period allocated to studying change in the panic disorder status was only 3 months. The control group received the intervention a few weeks after T ₁.In future research, longer follow-up is recommended to study changes in the incidence of panic disorder. Third, the extended follow-up in the treatment group was only 6 months following the conclusion of the course. Longer follow-up periods are needed to find out how long the beneficial effects will persist.

Implications

Overall, our findings carry the promise that prevention and early intervention through a brief group intervention for people with subthreshold or mild panic disorder can be effective. The selected target group is known to be reticent in asking professional help and it is therefore good to see that a low-threshold intervention is apparently regarded as accessible and acceptable.